BioSpace News Archive

Pharm Country

Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Vyant Bio, Inc. is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders.

November 16, 2022
·
3 min read
BioCapital

Owens & Minor to Participate in the 5th Annual Evercore ISI HealthCONx Conference

Owens & Minor, Inc. (NYSE: OMI) announced today that executive leadership will participate in a virtual fireside chat at the upcoming 5th Annual Evercore ISI HealthCONx Conference.

November 16, 2022
·
1 min read
Policy

FDA Spurs Innovation for Human Food from Animal Cell Culture Technology

The world is experiencing a food revolution and the U.S. Food and Drug Administration is committed to supporting innovation in the food supply.

November 16, 2022
·
4 min read
Antibody Drugs Market Size USD 1.2 BN by 2030 With a CAGR of 4.8%

According to Nova one advisor, the global Antibody Drugs market was valued at USD 560.7 million in 2021 and it is expected to hit around USD 1.2 billion by 2030 with a CAGR of 4.8% during the forecast period 2022 to 2030.

November 16, 2022
·
5 min read
BioMidwest

RaeSedo Inc. awarded $3.4M STTR Grant to Develop New Asthma Therapies

RaeSedo Inc., a spin-out of the University of Arizona developing novel therapies for asthma, is pleased to announce the award of a Phase 2 Small Business Technology Transfer grant awarding $3.4 million over two years to continue developing potential therapeutics.

November 16, 2022
·
1 min read
Deals

Stealth BioTherapeutics Corp Announces Completion of Merger

Stealth BioTherapeutics Corp announced the completion of the merger with Stealth Merger Sub Limited.

November 16, 2022
·
8 min read
Biotech Bay

Agilent Announces Cash Dividend of 22.5 Cents Per Share

Agilent Technologies Inc. announced the company has increased its quarterly dividend to 22.5 cents per share of common stock, reflecting a 7% increase over the previous quarter.

November 16, 2022
·
2 min read
BioMidwest

Biodesix Announces Proposed Public Offering of Common Stock - November 16, 2022

Biodesix, Inc. announced that it has commenced an underwritten public offering of $30 million of shares of its common stock, before deducting underwriting discounts and commissions and other offering expenses.

November 16, 2022
·
4 min read
Biotech Bay

Kodiak Sciences to Present at the Evercore ISI 5th Annual HealthCONx Conference

Kodiak Sciences Inc. (NASDAQ: KOD) announced today that management will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on Tuesday, November 29, 2022, at 9:10am Pacific Time (12:10pm Eastern Time).

November 16, 2022
·
2 min read